These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37213535)

  • 21. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
    Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
    J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of a novel computerized cognitive battery for mild cognitive impairment.
    Dwolatzky T; Whitehead V; Doniger GM; Simon ES; Schweiger A; Jaffe D; Chertkow H
    BMC Geriatr; 2003 Nov; 3():4. PubMed ID: 14594456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normative Data in Cross-Cultural Neuropsychological Instruments in Spaniards and Colombians Living in Spain.
    Delgado-Álvarez A; Delgado-Alonso C; Valles-Salgado M; Gil-Moreno MJ; Fernández-Romero L; Matías-Guiu J; Matias-Guiu JA
    J Alzheimers Dis; 2023; 96(3):1231-1241. PubMed ID: 37927267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apathy in individuals with Parkinson's disease associated with mild cognitive impairment. A neuropsychological investigation.
    Costa A; Peppe A; Zabberoni S; Scalici F; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2018 Sep; 118(Pt B):4-11. PubMed ID: 29787739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil.
    Brandão PRP; Pereira DA; Grippe TC; Bispo DDC; Maluf FB; Yunes MP; Nunes Filho G; Alves CHL; Pagonabarraga J; Kulisevsky J; da Costa AML; Serafim CFDV; Ferreira ACDB; Bastos AMM; Belchior ACF; de Almeida BLC; de Almeida E Castro BM; Matos MS; de Matos RC; Rios GA; Carneiro LO; da Mota BCC; Castro LEDR; Rocha VLS; Tavares MCH; Cardoso F
    Mov Disord Clin Pract; 2023 Mar; 10(3):452-465. PubMed ID: 36949793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIMHANS Neuropsychological Battery for Elderly in Parkinson's Disease Patients: Validation and Diagnosis using MDS PD-MCI Task Force Criteria in Indian Population.
    Botta R; Keshav KJ; Kutty B; Mahadevan A; Pal PK; Yadav R
    Ann Indian Acad Neurol; 2023; 26(3):247-255. PubMed ID: 37538425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mild Cognitive Impairment in Early Parkinson's Disease Using the Movement Disorder Society Task Force Criteria: Cross-Sectional Study in Hoehn and Yahr Stage 1.
    Stefanova E; Žiropadja L; Stojković T; Stanković I; Tomić A; Ječmenica-Lukić M; Petrović I; Kostić V
    Dement Geriatr Cogn Disord; 2015; 40(3-4):199-209. PubMed ID: 26226988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brazilian version of the European Cross-Cultural Neuropsychological Test Battery (CNTB-BR): diagnostic accuracy across schooling levels.
    Araujo NB; Nielsen TR; Barca ML; Engedal K; Marinho V; Deslandes AC; Coutinho ES; Laks J
    Braz J Psychiatry; 2020; 42(3):286-294. PubMed ID: 32130401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment.
    Dwolatzky T; Whitehead V; Doniger GM; Simon ES; Schweiger A; Jaffe D; Chertkow H
    J Mol Neurosci; 2004; 24(1):33-44. PubMed ID: 15314247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of verbal fluency tests in the discrimination of mild cognitive impairment and probable Alzheimer's disease in older Spanish monolingual individuals.
    García-Herranz S; Díaz-Mardomingo MC; Venero C; Peraita H
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Nov; 27(6):826-840. PubMed ID: 31822214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.